Skip to main content

Tibial Fractures clinical trials at University of California Health

3 in progress, 2 open to eligible people

Showing trials for
  • Effect of Palmitoylethanolamide on Reducing Opioid Consumption for Below Knee Fracture Fixation

    open to eligible people ages 18 years and up

    Palmitoylethanolamide (PEA), a non-psychoactive cannabis compound derived from peanuts, egg yolks, and soybeans, is an Endogenous FA Amide produced in the body as a biological response and a repair mechanism in chronic inflammation and chronic pain. In animal and clinical trials, PEA has also shown evidence of pain reduction, sleep improvement, and increased joint mobility and function with minimal side-effects. The study team intends to study whether the inclusion of PEA in conjunction with standard post-surgical medications can reduce pain and inflammation while decreasing the number of opioids needed.

    at UC Irvine

  • Effects of Early Weight Bearing on Rehabilitation Outcomes in Patients With Traumatic Ankle and Tibial Plateau Fractures

    open to eligible people ages 18 years and up

    The overall objective of this study is to compare outcomes following early versus delayed weight bearing for adult patients operatively treated for an ankle fracture without syndesmotic fixation. Additionally, early weight bearing will be tested in patients with unicondylar plateau fractures that do not involve joint impaction in the context of a pilot study.

    at UCSF

  • Early Advanced Weight Bearing for Peri-articular Knee and Pilon Injuries

    Sorry, in progress, not accepting new patients

    The overall objective of this study is to compare outcomes following early advanced weight bearing (EAWB) using the AlterG antigravity treadmill versus standard of care physical therapy for adult patients with lower extremity periarticular injuries.

    at UCSF

Our lead scientists for Tibial Fractures research studies include .

Last updated: